No headlines found.
No press releases found.
No news found.
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Geographically, the company derives revenue from PRC.
Concord Medical Services Holdings Limited American Depositary Shares (Each Represents Thirty (30) Class A Ordinary Shares) trades on the NYSE stock market under the symbol CCM.
As of September 10, 2026, CCM stock price declined to $3.95 with 4,080 million shares trading.
CCM has a beta of 1.26, meaning it tends to be more sensitive to market movements. CCM has a correlation of 0.04 to the broad based SPY ETF.
CCM has a market cap of $17.15 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, CCM traded as high as $10.77 and as low as $.38.
CCM has underperformed the market in the last year with a price return of -30.0% while the SPY ETF gained +17.3%. CCM has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -14.7% and -19.4%, respectively, while the SPY returned +4.7% and -1.7%, respectively.
CCM support price is $3.79 and resistance is $4.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CCM shares will trade within this expected range on the day.
